XHS - ETF AI Analysis

Top Page

SPDR S&P Health Care Services ETF (XHS)

Rating:66Neutral

Price Target:―

XHS, the SPDR S&P Health Care Services ETF, earns a solid overall rating driven largely by strong holdings like The Ensign Group and Tenet Healthcare, which benefit from robust revenue growth, strategic acquisitions or financial maneuvers, and generally positive outlooks. However, several holdings such as DaVita, Centene, and Brookdale Senior Living face profitability, leverage, or technical challenges that weigh on the fund, and investors should note the key risk that many constituents share high debt levels and pressured margins within the health care services sector.

Positive Factors

Broad Health Care Services Exposure

The ETF holds many different health care services companies, which helps spread risk within this specialized part of the market.

Strong Top Holdings Momentum

Most of the largest positions have shown strong year-to-date gains, which has supported the fund’s recent performance.

Moderate Expense Ratio

The fund’s fee is reasonable for a specialized sector ETF, allowing investors to keep more of their returns compared with many niche funds that charge higher costs.

Negative Factors

Single-Sector Concentration

With almost all assets in health care, the ETF is heavily exposed to changes in health care policy, regulation, and industry trends.

U.S.-Only Geographic Focus

The portfolio is almost entirely invested in U.S. companies, offering little diversification across different countries and economies.

Small Asset Base

The relatively low assets under management may mean lower trading volume and wider bid-ask spreads, which can increase trading costs for investors.

XHS vs. SPDR S&P 500 ETF (SPY)

AUM85.58M

RegionNorth America

Expense Ratio0.35%

Beta0.60

IssuerSPDR

Inception DateSep 28, 2011

Dividend Yield0.28%

Asset ClassEquity

Index TrackedS&P Health Care Services Select Industry

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume6,574

30 Day Avg. Volume9,138

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

131.86

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering60

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

XHS Summary

The SPDR S&P Health Care Services ETF (XHS) tracks the S&P Health Care Services Select Industry Index, focusing on U.S. companies that provide medical care and related services. It holds a mix of health insurers, senior living operators, and service providers, including well-known names like Centene and Cardinal Health. Someone might invest in XHS to get diversified exposure to the health care services theme, which can benefit from an aging population and steady demand for medical care. A key risk is that it is concentrated in one sector, so it can rise or fall sharply with changes in health care policy and costs.

How much will it cost me?The SPDR S&P Health Care Services ETF (XHS) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is a sector-focused fund, which typically requires more active management compared to broad-market index funds.

What would affect this ETF?The SPDR S&P Health Care Services ETF (XHS) could benefit from increasing demand for health care services driven by an aging population and advancements in medical technology, which support innovation and growth in its top holdings like NeoGenomics and Guardant Health. However, potential risks include regulatory changes or shifts in government health care policies that could impact profitability, as well as broader economic conditions that may affect consumer spending on health care services. With its strong focus on U.S.-based health care providers, the ETF is well-positioned to capitalize on the sector's resilience but remains sensitive to policy and economic fluctuations.

XHS Top 10 Holdings

XHS is very much a U.S. health‑care workhorse, with performance driven by a mix of rising hospital and services names. Tenet Healthcare, HCA Healthcare, and The Ensign Group have been powering ahead, giving the fund a solid backbone as demand for medical services stays strong. Brookdale Senior Living and DaVita are also climbing, though their heavy debt loads mean the ride isn’t entirely smooth. Centene, with more mixed and recently lagging action, is adding a bit of drag, but overall the ETF leans into health‑care providers as its clear, concentrated bet.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ACHC	Acadia Healthcare	3.65%	$3.12M	$2.17B	-17.59%	61 Neutral
BKD	Brookdale Senior Living	2.76%	$2.36M	$3.31B	129.28%	61 Neutral
DVA	DaVita	2.68%	$2.30M	$10.07B	5.07%	59 Neutral
ENSG	The Ensign Group	2.50%	$2.14M	$12.19B	67.23%	78 Outperform
MCK	McKesson	2.41%	$2.06M	$115.25B	44.66%	62 Neutral
THC	Tenet Healthcare	2.37%	$2.03M	$19.80B	85.56%	74 Outperform
HCA	HCA Healthcare	2.36%	$2.02M	$119.18B	66.87%	70 Neutral
DGX	Quest Diagnostics	2.33%	$1.99M	$21.94B	17.36%	79 Outperform
CON	Concentra Group Holdings Parent, Inc.	2.33%	$1.99M	$2.88B	7.60%	66 Neutral
CAH	Cardinal Health	2.30%	$1.97M	$51.08B	69.59%	66 Neutral

XHS Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

108.00

Negative

100DMA

106.98

Negative

200DMA

101.87

Positive

Market Momentum

MACD

-0.93

Positive

RSI

36.45

Neutral

STOCH

8.91

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XHS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 107.20, equal to the 50-day MA of 108.00, and equal to the 200-day MA of 101.87, indicating a neutral trend. The MACD of -0.93 indicates Positive momentum. The RSI at 36.45 is Neutral, neither overbought nor oversold. The STOCH value of 8.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XHS.

XHS Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
XHS	―	―	$85.58M	0.35%	66 Neutral
LFSC	―	―	$90.59M	0.54%	55 Neutral
IBBQ	―	―	$72.05M	0.19%	66 Neutral
BBP	―	―	$48.86M	0.34%	60 Neutral
BBC	―	―	$37.31M	0.65%	48 Neutral
FTXH	―	―	$28.72M	0.60%	73 Outperform

Performance Comparison

XHS

SPDR S&P Health Care Services ETF

103.63

6.93

7.17%

LFSC

F/M Emerald Life Sciences Innovation ETF

―

IBBQ

Invesco Nasdaq Biotechnology ETF

―

BBP

Virtus LifeSci Biotech Products ETF

―

BBC

Virtus LifeSci Biotech Clinical Trials ETF

―

FTXH

First Trust Nasdaq Pharmaceuticals ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents